A committee, including Adipogen, made guidelines for antibody validation & detailed context-dependent measures to be followed by antibody suppliers.
September 2016: The Antibody Update From ProSci
ProSci’s top news picks for September 2016 include a paper on a novel monoclonal antibody against parenchymal amyloid-beta for the treatment of Alzheimer’s Dementia, a scientist using CRISPR for gene editing of embryos, and an update on the discussion of
June 2016: The Antibody Update from ProSci
This months ProSci Antibody Update’s news includes the first CRISPR/Cas9 cancer therapeutic’s entry into clinical trials, how mosquito saliva assists viruses in proliferation, and the latest update on antibody validation. First CRISPR/Cas9 Therapeutic Clinical Trials StartingProSci Blog Antibody UpdateCRISPR Cas9
Tips for Understanding the Reproducibility Crisis
An article published by Nature earlier this year pointed out that researchers now have to worry about the reproducibility of production antibodies. The fact of the matter is that off-the-shelf antibodies from large distributors can be unreliable tools, often functioning